Modelling gene-environment interaction in first episodes of psychosis

Schizophrenia Research

Volumn 189, Issue , 2017, Pages 181-189

  Bernardo, Miguel ^a,b   Bioque, Miquel ^a   Cabrera, Bibiana ^a   Lobo, Antonio ^c   González Pinto, Ana ^d   Pina, Laura ^e   Corripio, Iluminada ^f   Sanjuán, Julio ^g   Mané, Anna ^h   Castro Fornieles, Josefina ^b   Vieta, Eduard ^b   Arango, Celso ^e   Mezquida, Gisela ^a   Gassó, Patricia ^b   Parellada, Mara ^e   Saiz Ruiz, Jerónimo ⁱ   Cuesta, Manuel J ^j   Mas, Sergi ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF ZARAGOZA   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^e UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^g UNIVERSITY OF VALENCIA   (Spain)

^h HOSPITAL DEL MAR   (Spain)

ⁱ HOSPITAL RAMÓN Y CAJAL   (Spain)

^j Universidad Pública de Navarra   (Spain)

more..

Author keywords

First episodes psychosis; Gene environment interaction; Predictive model; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DTNBP1 GENE; ENTROPY; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HOMOZYGOSITY; HTR2C GENE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MAOA GENE; MAOB GENE; NEUROTRANSMISSION; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SLC18A2 GENE; SLC6A4 GENE; SP4 GENE; ADOLESCENT; BIOLOGICAL MODEL; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; MULTICENTER STUDY; ODDS RATIO; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; SPAIN; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MODELS, BIOLOGICAL; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; SPAIN; YOUNG ADULT;

EID: 85011586102     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2017.01.058     Document Type: Article

References (52)

1. Aas, M., Djurovic, S., Athanasiu, L., Steen, N.E., Agartz, I., Lorentzen, S., Sundet, K., Andreassen, O.A., Melle, I., Serotonin transporter gene polymorphism, childhood trauma, and cognition in patients with psychotic disorders. Schizophr. Bull. 38:1 (2012), 15–22.
2. Ahmed, A.A., Ma, W., Ni, Y., Zhou, Q., Zhao, R., Embryonic exposure to corticosterone modifies aggressive behavior through alterations of the hypothalamic pituitary adrenal axis and the serotonergic system in the chicken. Horm. Behav. 65:2 (2013), 97–105.
3. Alex, K.D., Pehek, E.A., Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol. Ther. 113:2 (2007), 296–320.
4. Arnedo, J., Svrakic, D.M., Val, C.D., Romero-Zaliz, R., Hernández-Cuervo, H., Consortium, M.G.O.S., Fanous, A.H., Pato, M.T., Pato, C.N., Erausquin, G.A.D., Cloninger, C.R., Zwir, I., Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies. Am. J. Psychiatr. 172:2 (2015), 139–153.
5. Austin, S.F., Mors, O., Secher, R.G., Hjorthøj, C.R., Albert, N., Bertelsen, M., Jensen, H., Jeppesen, P., Petersen, L., Randers, L., Thorup, A., Nordentoft, M., Predictors of recovery in first episode psychosis: the OPUS cohort at 10 year follow-up. Schizophr. Res. 150:1 (2014), 163–168.
6. Bernardo, M., Bioque, M., What have we learned from research into first-episode psychosis?. Rev. Psiquiatr. Salud Ment. 7:2 (2014), 61–63.
7. Bernardo, M., Bioque, M., Parellada, M., Saiz Ruiz, J., Cuesta, M.J., Llerena, A., Sanjuan, J., Castro-Fornieles, J., Arango, C., Cabrera, B., Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs). Rev. Psiquiatr. Salud Ment. 6:1 (2013), 4–16.
8. Bertelsen, M., Jeppesen, P., Petersen, L., Thorup, A., Ohlenschlaeger, J., le Quach, P., Christensen, T.O., Krarup, G., Jorgensen, P., Nordentoft, M., Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Arch. Gen. Psychiatry 65:7 (2008), 762–771.
9. Bielas, H., Arck, P., Bruenahl, C.A., Walitza, S., Grunblatt, E., Prenatal stress increases the striatal and hippocampal expression of correlating c-FOS and serotonin transporters in murine offspring. Int. J. Dev. Neurosci. 38 (2008), 30–35.
10. Boog, G., Obstetrical complications and subsequent schizophrenia in adolescent and young adult offsprings: is there a relationship?. Eur. J. Obstet. Gynecol. Reprod. Biol. 114:2 (2004), 130–136.
11. Booij, L., Tremblay, R.E., Szyf, M., Benkelfat, C., Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology. J. Psychiatry Neurosci. 40:1 (2014), 5–18.
12. Bubar, M.J., Cunningham, K.A., Distribution of serotonin 5-HT2C receptors in the ventral tegmental area. Neuroscience 146:1 (2007), 286–297.
13. Castro-Fornieles, J., Parellada, M., Soutullo, C.A., Baeza, I., Gonzalez-Pinto, A., Graell, M., Paya, B., Moreno, D., de la Serna, E., Arango, C., Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach. J. Child Adolesc. Psychopharmacol. 18:4 (2008), 327–336.
14. Clark, J.A., Pai, L.Y., Flick, R.B., Rohrer, S.P., Differential hormonal regulation of tryptophan hydroxylase-2 mRNA in the murine dorsal raphe nucleus. Biol. Psychiatry 57:8 (2005), 943–946.
15. Curk, T., Demsar, J., Xu, Q., Leban, G., Petrovic, U., Bratko, I., Shaulsky, G., Zupan, B., Microarray data mining with visual programming. Bioinformatics 21:3 (2005), 396–398.
16. Czyrak, A., Mackowiak, M., Chocyk, A., Fijal, K., Wedzony, K., Role of glucocorticoids in the regulation of dopaminergic neurotransmission. Pol. J. Pharmacol. 55:5 (2003), 667–674.
17. Chaumette, B., Kebir, O., Mam-Lam-Fook, C.l., Morvan, Y., Bourgin, J., Godsil, B.P., Plaze, M., Gaillard, R.l., Jay, T.R.S.M., Krebs, M.-O., Salivary cortisol in early psychosis: new findings and meta-analysis. Psychoneuroendocrinology 63 (2016), 262–270.
18. Dalton, V.S., Verdurand, M., Walker, A., Hodgson, D.M., Zavitsanou, K., Synergistic effect between maternal infection and adolescent cannabinoid exposure on serotonin 5HT1A receptor binding in the hippocampus: testing the “two hit” hypothesis for the development of schizophrenia. ISRN Psychiatry, 2012, 2012, 451865.
19. Daskalakis, N.P., Binder, E.B., Schizophrenia in the spectrum of gene-stress interactions: the FKBP5 example. Schizophr. Bull. 41:2 (2015), 323–329.
20. Di Giovanni, G., Di Matteo, V., Di Mascio, M., Esposito, E., Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study. Synapse 35:1 (2000), 53–61.
21. Di Matteo, V., Di Giovanni, G., Di Mascio, M., Esposito, E., SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38:8 (1999), 1195–1205.
22. European Network of National Networks studying Gene-Environment Interactions in Schizophrenia, van Os, J., Rutten, B.P., Myin-Germeys, I., Delespaul, P., Viechtbauer, W., van Zelst, C., Bruggeman, R., Reininghaus, U., Morgan, C., Murray, R.M., Di Forti, M., McGuire, P., Valmaggia, L.R., Kempton, M.J., Gayer-Anderson, C., Hubbard, K., Beards, S., Stilo, S.A., Onyejiaka, A., Bourque, F., Modinos, G., Tognin, S., Calem, M., O'Donovan, M.C., Owen, M.J., Holmans, P., Williams, N., Craddock, N., Richards, A., Humphreys, I., Meyer-Lindenberg, A., Leweke, F.M., Tost, H., Akdeniz, C., Rohleder, C., Bumb, J.M., Schwarz, E., Alptekin, K., Ucok, A., Saka, M.C., Atbasoglu, E.C., Guloksuz, S., Gumus-Akay, G., Cihan, B., Karadag, H., Soygur, H., Cankurtaran, E.S., Ulusoy, S., Akdede, B., Binbay, T., Ayer, A., Noyan, H., Karadayi, G., Akturan, E., Ulas, H., Arango, C., Parellada, M., Bernardo, M., Sanjuan, J., Bobes, J., Arrojo, M., Santos, J.L., Cuadrado, P., Rodriguez Solano, J.J., Carracedo, A., Garcia Bernardo, E., Roldan, L., Lopez, G., Cabrera, B., Cruz, S., Diaz Mesa, E.M., Pouso, M., Jimenez, E., Sanchez, T., Rapado, M., Gonzalez, E., Martinez, C., Sanchez, E., Olmeda, M.S., de Haan, L., Velthorst, E., van der Gaag, M., Selten, J.P., van Dam, D., van der Ven, E., van der Meer, F., Messchaert, E., Kraan, T., Burger, N., Leboyer, M., Szoke, A., Schurhoff, F., Llorca, P.M., Jamain, S., Tortelli, A., Frijda, F., Vilain, J., Galliot, A.M., Baudin, G., Ferchiou, A., Richard, J.R., Bulzacka, E., Charpeaud, T., Tronche, A.M., De Hert, M., van Winkel, R., Decoster, J., Derom, C., Thiery, E., Stefanis, N.C., Sachs, G., Aschauer, H., Lasser, I., Winklbaur, B., Schlogelhofer, M., Riecher-Rossler, A., Borgwardt, S., Walter, A., Harrisberger, F., Smieskova, R., Rapp, C., Ittig, S., Soguel-dit-Piquard, F., Studerus, E., Klosterkotter, J., Ruhrmann, S., Paruch, J., Julkowski, D., Hilboll, D., Sham, P.C., Cherny, S.S., Chen, E.Y., Campbell, D.D., Li, M., Romeo-Casabona, C.M., Emaldi Cirion, A., Urruela Mora, A., Jones, P., Kirkbride, J., Cannon, M., Rujescu, D., Tarricone, I., Berardi, D., Bonora, E., Seri, M., Marcacci, T., Chiri, L., Chierzi, F., Storbini, V., Braca, M., Minenna, M.G., Donegani, I., Fioritti, A., La Barbera, D., La Cascia, C.E., Mule, A., Sideli, L., Sartorio, R., Ferraro, L., Tripoli, G., Seminerio, F., Marinaro, A.M., McGorry, P., Nelson, B., Amminger, G.P., Pantelis, C., Menezes, P.R., Del-Ben, C.M., Gallo Tenan, S.H., Shuhama, R., Ruggeri, M., Tosato, S., Lasalvia, A., Bonetto, C., Ira, E., Nordentoft, M., Krebs, M.O., Barrantes-Vidal, N., Cristobal, P., Kwapil, T.R., Brietzke, E., Bressan, R.A., Gadelha, A., Maric, N.P., Andric, S., Mihaljevic, M., Mirjanic, T., Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr. Bull. 40:4 (2014), 729–736.
23. Fan, R., Zhong, M., Wang, S., Zhang, Y., Andrew, A., Karagas, M., Chen, H., Amos, C.I., Xiong, M., Moore, J.H., Entropy-based information gain approaches to detect and to characterize gene-gene and gene-environment interactions/correlations of complex diseases. Genet. Epidemiol. 35:7 (2011), 706–721.
24. Franklin, J.M., Mathew, M., Carrasco, G.A., Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats. Neurosci. Lett. 548 (2013), 165–169.
25. Ghiani, C.A., Starcevic, M., Rodriguez-Fernandez, I.A., Nazarian, R., Cheli, V.T., Chan, L.N., Malvar, J.S., de Vellis, J., Sabatti, C., Dell'Angelica, E.C., The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth. Mol. Psychiatry 15:2 (2010), 204–215.
26. Glover, V., Prenatal stress and its effects on the fetus and the child: possible underlying biological mechanisms. Adv. Neurobiol. 10 (2015), 269–283.
27. Gobert, A., Rivet, J.M., Lejeune, F., Newman-Tancredi, A., Adhumeau-Auclair, A., Nicolas, J.P., Cistarelli, L., Melon, C., Millan, M.J., Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36:3 (2000), 205–221.
28. Gonzalez, J.R., Armengol, L., Sole, X., Guino, E., Mercader, J.M., Estivill, X., Moreno, V., SNPassoc: an R package to perform whole genome association studies. Bioinformatics 23:5 (2007), 644–645.
29. Holloway, T., Moreno, J.L., Umali, A., Rayannavar, V., Hodes, G.E., Russo, S.J., Gonzalez-Maeso, J., Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system. J. Neurosci. 33:3 (2013), 1088–1098.
30. Howes, O.D., McDonald, C., Cannon, M., Arseneault, L., Boydell, J., Murray, R.M., Pathways to schizophrenia: the impact of environmental factors. Int. J. Neuropsychopharmacol. 7:Suppl. 1 (2004), S7–S13.
31. Insel, T.R., The NIMH research domain criteria (RDoC) project: precision medicine for psychiatry. Am. J. Psychiatry 171:4 (2014), 395–397.
32. Jensen, N.H., Cremers, T.I., Sotty, F., Therapeutic potential of 5-HT2C receptor ligands. ScientificWorldJournal 10 (2010), 1870–1885.
33. Kahn, R.S., Fleischhacker, W.W., Boter, H., Davidson, M., Vergouwe, Y., Keet, I.P., Gheorghe, M.D., Rybakowski, J.K., Galderisi, S., Libiger, J., Hummer, M., Dollfus, S., Lopez-Ibor, J.J., Hranov, L.G., Gaebel, W., Peuskens, J., Lindefors, N., Riecher-Rossler, A., Grobbee, D.E., Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 371:9618 (2008), 1085–1097.
34. Kapur, S., Phillips, A.G., Insel, T.R., Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?. Mol. Psychiatry 17:12 (2012), 1174–1179.
35. Kofman, O., The role of prenatal stress in the etiology of developmental behavioural disorders. Neurosci. Biobehav. Rev. 26:4 (2002), 457–470.
36. Lasalvia, A., Bonetto, C., Tosato, S., Zanatta, G., Cristofalo, D., Salazzari, D., Lazzarotto, L., Bertani, M., Bissoli, S., De Santi, K., Cremonese, C., De Rossi, M., Gardellin, F., Ramon, L., Zucchetto, M., Amaddeo, F., Tansella, M., Ruggeri, M., Group, T.P.-V, First-contact incidence of psychosis in north-eastern Italy: influence of age, gender, immigration and socioeconomic deprivation. Br. J. Psychiatry 205:2 (2014), 127–134.
37. Matheson, S.L., Shepherd, A.M., Laurens, K.R., Carr, V.J., A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. Schizophr. Res. 133:1–3 (2011), 133–142.
38. McEvoy, J.P., Lieberman, J.A., Perkins, D.O., Hamer, R.M., Gu, H., Lazarus, A., Sweitzer, D., Olexy, C., Weiden, P., Strakowski, S.D., Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. Am. J. Psychiatry 164:7 (2007), 1050–1060.
39. Modinos, G., Iyegbe, C., Prata, D., Rivera, M., Kempton, M.J., Valmaggia, L.R., Sham, P.C., van Os, J., McGuire, P., Molecular genetic gene–environment studies using candidate genes in schizophrenia: a systematic review. Schizophr. Res. 150:2 (2013), 356–365.
40. Moore, J.H., Gilbert, J.C., Tsai, C.T., Chiang, F.T., Holden, T., Barney, N., White, B.C., A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J. Theor. Biol. 241:2 (2006), 252–261.
41. Moreno-Ramos, O.A., Lattig, M.C., Gonzalez Barrios, A.F., Modeling of the hypothalamic-pituitary-adrenal axis-mediated interaction between the serotonin regulation pathway and the stress response using a Boolean approximation: a novel study of depression. Theor. Biol. Med. Model., 10, 2013, 59.
42. Nugent, A.C., Bain, E.E., Carlson, P.J., Neumeister, A., Bonne, O., Carson, R.E., Eckelman, W., Herscovitch, P., Zarate, C.A. Jr., Charney, D.S., Drevets, W.C., Reduced post-synaptic serotonin type 1A receptor binding in bipolar depression. Eur. Neuropsychopharmacol 23:8 (2013), 822–829.
43. Olesen, J., Gustavsson, A., Svensson, M., Wittchen, H.U., Jonsson, B., The economic cost of brain disorders in Europe. Eur. J. Neurol. 19:1 (2011), 155–162.
44. Perala, J., Suvisaari, J., Saarni, S.I., Kuoppasalmi, K., Isometsa, E., Pirkola, S., Partonen, T., Tuulio-Henriksson, A., Hintikka, J., Kieseppa, T., Harkanen, T., Koskinen, S., Lonnqvist, J., Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch. Gen. Psychiatry 64:1 (2007), 19–28.
45. Schizophrenia Working Group of the Psychiatric Genomics, C, Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:7510 (2014), 421–427.
46. Sidhu, A., Wersinger, C., Vernier, P., Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?. FASEB J. 18:6 (2004), 637–647.
47. Sullivan, P.F., Kendler, K.S., Neale, M.C., Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60:12 (2003), 1187–1192.
48. Tandon, R., Keshavan, M.S., Nasrallah, H.A., Schizophrenia, “just the facts”: what we know in 2008 part 1: overview. Schizophr. Res. 100:1–3 (2008), 4–19.
49. Torrey, E.F., Bartko, J.J., Yolken, R.H., Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr. Bull. 38:3 (2012), 642–647.
50. van Winkel, R., Stefanis, N.C., Myin-Germeys, I., Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr. Bull. 34:6 (2008), 1095–1105.
51. Walker, E., Mittal, V., Tessner, K., Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu. Rev. Clin. Psychol. 4 (2008), 189–216.
52. Zhang, J., Fan, Y., Li, Y., Zhu, H., Wang, L., Zhu, M.Y., Chronic social defeat up-regulates expression of the serotonin transporter in rat dorsal raphe nucleus and projection regions in a glucocorticoid-dependent manner. J. Neurochem. 123:6 (2012), 1054–1068.